Advertisement

The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol

Placebo-controlled Hiv Study

Here's a taste of what TheBody.com has to offer on this topic:
Ask the Experts

How do I know what is a placebo effect?

I have been reading about the placebo effect. Some of us are taking supplements and say they are helping us. Are they really helping us or is it the placebo effect? How long does the placebo effect last, Nelson?
Nelson Vergel, B.S.Ch.E., M.B.A.

Response from Nelson Vergel, B.S.Ch.E., M.B.A.

Program for Wellness Restoration
...complementary therapy they are using is helping them, then that is all that matters (as long as there are no negative interactions with HIV drug blood levels, which is unfortunately an area that has little data in HIV)Nelson Read more »

LDN

I recently received my latest labs and based on my CD4 and CD4 %, treatment is suggested. I read... Read more »

Immune boosters and supplements

Hi DocMy husband is HIV positive and on ARVs. Can he possibly as well take some immune boosters... Read more »
Articles
Henry J. Kaiser Family Foundation

Leaders of Merck's Canceled HIV Vaccine Study Notify Participants Whether They Received Vaccine, Placebo

...were testing the same vaccine have told the 801 participants in the separate trial if they received the vaccine ( Kaiser Daily HIV/AIDS Report , 11/12). According to the Chronicle , there was a "compelling ethical case" to unblind the study... Read more »
The Body PRO

Poster Session 22343: A Phase III, Double-Blind, Placebo-Controlled, Multi-Center Study to Determine the Effectiveness and Tolerability of the Combination of Efavirenz and Indinavir (IDV) versus Indinavir in HIV-1 Infected Patients Receiving Nucleoside Analogue (NRTI) Therapy at 24 Weeks

This study of 300 patients with at least 8 weeks of experience with nucleoside reverse transcriptase inhibitor (NRTI) therapy compared the three drug combination of IDV plus 2 NRTIs (patient's choice) with the FOUR drug combination of efavirenz,... Read more »
The Body PRO

Trend Toward Fewer AIDS-Defining Conditions Among Patients Receiving Raltegravir vs. Placebo

...results of studies directly from those who actually conducted the research. In this interview, you'll meet one of these impressive HIV researchers and read his explanation of the study he presented at ICAAC/IDSA 2008. I'm Joe Eron , from the... Read more »
U.S. Centers for Disease Control and Prevention

Safety and Immunogenicity of Hepatitis A Vaccine in HIV-Infected Patients: A Double-Blind, Randomized, Placebo-Controlled Trial

...(HepA) vaccine provides affordable protection against HAV infection, which may be of particular importance in those who are HIV-infected. One of the inactivated HepA vaccines, HAVRIX, is highly immunogenic in non HIV-infected adults, resulting in... Read more »
Connect With Others

New Research Study for NYC HIV+ Men

Posted by ProjectACE
...Im just here to spread the word about a new Research study in the NYC area. This study looks at HIV+ mens use of drugs and medication. This is a great way to help the community. Receive up to $430 for your time. We are LGBT Read more »

aids related dimentia..

Posted by AIDS2HIV, 1 Reply
...a common anticonvulsant drug improved cognitive function and appeared to restore nerve cells in the brains of patients with HIV-related dementia. The results of the Phase I clinical trial are published in the March issue of the scientific journal... Read more »

More Promise for Hope

Posted by Survivor, 2 Replies
...keep their virus levels in check for a year or more. What makes DeLane's case important is that he is among a small group of HIV-infected men and women participating in an unusual experiment. Half of them have had their own blood cells modified... Read more »

Has anyone seen this?

Posted by Anonymous
...Hospital in London. (Full biographies of Board members may be found at the conclusion of this release.) "The global HIV/AIDS epidemic continues to expand without adequate control of transmission or progression from infection to... Read more »